Zeto Secures $31M in Series B Funding for EEG Innovation
Zeto, Inc., a pioneering medical technology company, has successfully secured $31 million in Series B funding. This significant investment was led by MindWorks Global (MWG), a Michigan-based investment entity known for its track record of building multi-billion-dollar enterprises. The funding will enable Zeto to expand its commercial and operational teams, drive further growth, and strengthen ongoing research and development efforts.
Zeto is at the forefront of advancing EEG brain monitoring and diagnostics in healthcare. The company’s innovative wearable devices and AI-driven cloud platform make brain monitoring accessible in diverse clinical settings, including the ICU, ED, hospitals, offices, and at home. Zeto’s EEG systems, which received FDA clearances in 2018 and 2024, are currently commercially available in the United States.
Mike Williams, Founder, CEO, and Lead Partner of MindWorks Global, expressed his enthusiasm for Zeto’s vision and technology, stating that they are truly transformative for the medical arena and beyond. He emphasized that the world of EEG is poised for immense transformation in the upcoming years, and Zeto will be at the forefront of this change. Williams noted that brain health assessment will extend beyond traditional healthcare, and MindWorks Global is excited to support Zeto in pioneering new frontiers.
Aswin Gunasekar, Zeto’s Founder and CEO, highlighted that this funding marks a pivotal milestone for the company. He mentioned that Zeto has earned a reputation for game-changing innovation and has experienced rapid adoption of its solutions by leading healthcare institutions across the U.S. Gunasekar expressed his excitement about collaborating with accomplished entrepreneur-investors who have successfully scaled companies to drive meaningful societal impact and significant revenue.
Zeto’s management team has long aspired to work with investors who bring not only capital but also invaluable expertise, extensive experience, and a powerful network. The company is grateful for the steadfast support and continued investments from its prior investors over the years. This new funding will enable Zeto to expand its capabilities to detect and manage conditions like depression, stroke, and traumatic brain injury.
Zeto’s innovative approach to EEG diagnostics has been recognized through its award-winning technology. The company’s zEEG headset and software platform are designed to make EEG capture more convenient and accessible. Zeto’s customer, Wave Neuroscience, Inc., has praised the company for transforming the way EEG capture is thought about, advancing technology further in the past two years than the industry had in the prior three or four decades.
With this significant investment, Zeto is poised to continue revolutionizing EEG diagnostics and expanding its reach in the healthcare industry. The company’s commitment to innovation and its partnership with MindWorks Global position it for continued growth and success in the years to come.
See more funded startups in USA.